Clinical utility of bone mass measurements in adults: Consensus of an international panel

P. D. Miller; S. L. Bonnick; C. J. Rosen; R. D. Altman; L. V. Avioli; J. Dequeker; D. Felsenberg; H. K. Genant; C. Gennari; K. D. Harper; A. B. Hodsman; M. Kleerekoper; C. A. Mautalen; M. R. McClung; P. J. Meunier; D. A. Nelson; N. F.A. Peel; L. G. Raisz; R. R. Recker

doi:10.1016/S0049-0172(96)80001-1

Clinical utility of bone mass measurements in adults: Consensus of an international panel

P. D. Miller, S. L. Bonnick, C. J. Rosen, R. D. Altman, L. V. Avioli, J. Dequeker, D. Felsenberg, H. K. Genant, C. Gennari, K. D. Harper, A. B. Hodsman, M. Kleerekoper, C. A. Mautalen, M. R. McClung, P. J. Meunier, D. A. Nelson, N. F.A. Peel, L. G. Raisz, R. R. Recker

Department of Medicine

Research output: Contribution to journal › Article › peer-review

84 Scopus citations

Abstract

Low bone mass predicts future fracture risk as well as high cholesterol or high blood pressure can predict the risk of heart disease or stroke. Prevention of the first fracture should be a clinical goal. In patients without fractures, osteopenia and osteoporosis can be diagnosed based on the extent of reduction in bone mass below mean peak bone mass of young healthy individuals. As bone mass decreases, fracture risk increases exponentially. Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebral abnormalities, radiographic osteopenia, asymptomatic primary hyperparathyroidism, and long-term corticosteroid therapy. Serial measurements can also be used to monitor the effects of osteoporosis treatments. The appropriate technique and skeletal site for bone mass measurements should be chosen based on the patient's circumstances and the precision of measurement. A clinical interpretation can enhance the value of computer-generated bone mass measurement reports and improve decision making.

Original language	English (US)
Pages (from-to)	361-372
Number of pages	12
Journal	Seminars in Arthritis and Rheumatism
Volume	25
Issue number	6
DOIs	https://doi.org/10.1016/S0049-0172(96)80001-1
State	Published - 1996

All Science Journal Classification (ASJC) codes

Rheumatology
Anesthesiology and Pain Medicine

Access to Document

10.1016/S0049-0172(96)80001-1

Fingerprint Dive into the research topics of 'Clinical utility of bone mass measurements in adults: Consensus of an international panel'. Together they form a unique fingerprint.

Cite this

Miller, P. D., Bonnick, S. L., Rosen, C. J., Altman, R. D., Avioli, L. V., Dequeker, J., Felsenberg, D., Genant, H. K., Gennari, C., Harper, K. D., Hodsman, A. B., Kleerekoper, M., Mautalen, C. A., McClung, M. R., Meunier, P. J., Nelson, D. A., Peel, N. F. A., Raisz, L. G., & Recker, R. R. (1996). Clinical utility of bone mass measurements in adults: Consensus of an international panel. Seminars in Arthritis and Rheumatism, 25(6), 361-372. https://doi.org/10.1016/S0049-0172(96)80001-1

Clinical utility of bone mass measurements in adults : Consensus of an international panel. / Miller, P. D.; Bonnick, S. L.; Rosen, C. J.; Altman, R. D.; Avioli, L. V.; Dequeker, J.; Felsenberg, D.; Genant, H. K.; Gennari, C.; Harper, K. D.; Hodsman, A. B.; Kleerekoper, M.; Mautalen, C. A.; McClung, M. R.; Meunier, P. J.; Nelson, D. A.; Peel, N. F.A.; Raisz, L. G.; Recker, R. R.

In: Seminars in Arthritis and Rheumatism, Vol. 25, No. 6, 1996, p. 361-372.

Research output: Contribution to journal › Article › peer-review

Miller, PD, Bonnick, SL, Rosen, CJ, Altman, RD, Avioli, LV, Dequeker, J, Felsenberg, D, Genant, HK, Gennari, C, Harper, KD, Hodsman, AB, Kleerekoper, M, Mautalen, CA, McClung, MR, Meunier, PJ, Nelson, DA, Peel, NFA, Raisz, LG & Recker, RR 1996, 'Clinical utility of bone mass measurements in adults: Consensus of an international panel', Seminars in Arthritis and Rheumatism, vol. 25, no. 6, pp. 361-372. https://doi.org/10.1016/S0049-0172(96)80001-1

Miller, P. D. ; Bonnick, S. L. ; Rosen, C. J. ; Altman, R. D. ; Avioli, L. V. ; Dequeker, J. ; Felsenberg, D. ; Genant, H. K. ; Gennari, C. ; Harper, K. D. ; Hodsman, A. B. ; Kleerekoper, M. ; Mautalen, C. A. ; McClung, M. R. ; Meunier, P. J. ; Nelson, D. A. ; Peel, N. F.A. ; Raisz, L. G. ; Recker, R. R. / Clinical utility of bone mass measurements in adults : Consensus of an international panel. In: Seminars in Arthritis and Rheumatism. 1996 ; Vol. 25, No. 6. pp. 361-372.

@article{2a093e4801284b26a0d5e48feef329ff,

title = "Clinical utility of bone mass measurements in adults: Consensus of an international panel",

abstract = "Low bone mass predicts future fracture risk as well as high cholesterol or high blood pressure can predict the risk of heart disease or stroke. Prevention of the first fracture should be a clinical goal. In patients without fractures, osteopenia and osteoporosis can be diagnosed based on the extent of reduction in bone mass below mean peak bone mass of young healthy individuals. As bone mass decreases, fracture risk increases exponentially. Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebral abnormalities, radiographic osteopenia, asymptomatic primary hyperparathyroidism, and long-term corticosteroid therapy. Serial measurements can also be used to monitor the effects of osteoporosis treatments. The appropriate technique and skeletal site for bone mass measurements should be chosen based on the patient's circumstances and the precision of measurement. A clinical interpretation can enhance the value of computer-generated bone mass measurement reports and improve decision making.",

author = "Miller, {P. D.} and Bonnick, {S. L.} and Rosen, {C. J.} and Altman, {R. D.} and Avioli, {L. V.} and J. Dequeker and D. Felsenberg and Genant, {H. K.} and C. Gennari and Harper, {K. D.} and Hodsman, {A. B.} and M. Kleerekoper and Mautalen, {C. A.} and McClung, {M. R.} and Meunier, {P. J.} and Nelson, {D. A.} and Peel, {N. F.A.} and Raisz, {L. G.} and Recker, {R. R.}",

year = "1996",

doi = "10.1016/S0049-0172(96)80001-1",

language = "English (US)",

volume = "25",

pages = "361--372",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Clinical utility of bone mass measurements in adults

T2 - Consensus of an international panel

AU - Miller, P. D.

AU - Bonnick, S. L.

AU - Rosen, C. J.

AU - Altman, R. D.

AU - Avioli, L. V.

AU - Dequeker, J.

AU - Felsenberg, D.

AU - Genant, H. K.

AU - Gennari, C.

AU - Harper, K. D.

AU - Hodsman, A. B.

AU - Kleerekoper, M.

AU - Mautalen, C. A.

AU - McClung, M. R.

AU - Meunier, P. J.

AU - Nelson, D. A.

AU - Peel, N. F.A.

AU - Raisz, L. G.

AU - Recker, R. R.

PY - 1996

Y1 - 1996

N2 - Low bone mass predicts future fracture risk as well as high cholesterol or high blood pressure can predict the risk of heart disease or stroke. Prevention of the first fracture should be a clinical goal. In patients without fractures, osteopenia and osteoporosis can be diagnosed based on the extent of reduction in bone mass below mean peak bone mass of young healthy individuals. As bone mass decreases, fracture risk increases exponentially. Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebral abnormalities, radiographic osteopenia, asymptomatic primary hyperparathyroidism, and long-term corticosteroid therapy. Serial measurements can also be used to monitor the effects of osteoporosis treatments. The appropriate technique and skeletal site for bone mass measurements should be chosen based on the patient's circumstances and the precision of measurement. A clinical interpretation can enhance the value of computer-generated bone mass measurement reports and improve decision making.

AB - Low bone mass predicts future fracture risk as well as high cholesterol or high blood pressure can predict the risk of heart disease or stroke. Prevention of the first fracture should be a clinical goal. In patients without fractures, osteopenia and osteoporosis can be diagnosed based on the extent of reduction in bone mass below mean peak bone mass of young healthy individuals. As bone mass decreases, fracture risk increases exponentially. Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebral abnormalities, radiographic osteopenia, asymptomatic primary hyperparathyroidism, and long-term corticosteroid therapy. Serial measurements can also be used to monitor the effects of osteoporosis treatments. The appropriate technique and skeletal site for bone mass measurements should be chosen based on the patient's circumstances and the precision of measurement. A clinical interpretation can enhance the value of computer-generated bone mass measurement reports and improve decision making.

UR - http://www.scopus.com/inward/record.url?scp=0029885623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029885623&partnerID=8YFLogxK

U2 - 10.1016/S0049-0172(96)80001-1

DO - 10.1016/S0049-0172(96)80001-1

M3 - Article

C2 - 8792508

AN - SCOPUS:0029885623

VL - 25

SP - 361

EP - 372

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 6

ER -